{"id":"W2294633761","doi":"10.1093/annonc/mdw133","title":"Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Myriad Genetics; AstraZeneca","keywords":"Olaparib; Medicine; Internal medicine; Ovarian cancer; Oncology; PARP inhibitor; Population; BRCA mutation; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002185695,0.0004671973,0.001589684,0.0005081713,0.0002135198,0.0008657248,0.0003135794,0.0005909934,0.0008120106],"category_scores_gemma":[0.002827371,0.0003291527,0.00126082,0.0008027087,0.0003805924,0.0008007857,0.0003024683,0.00105104,0.0001653198],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000506548,"about_ca_system_score_gemma":0.0004201416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002382249,"about_ca_topic_score_gemma":0.0006641567,"domain_scores_codex":[0.9984118,0.0009951756,0.0001379708,0.0002004918,0.0001564019,0.00009822841],"domain_scores_gemma":[0.9975987,0.001154704,0.0006726778,0.0002084522,0.00009868943,0.0002668106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3863157,0.002787156,0.4115059,0.0009438662,0.01579443,0.0005985122,0.00025423,0.003052434,0.01508766,0.0002604696,0.002190691,0.1612089],"study_design_scores_gemma":[0.09267733,0.09572542,0.7778997,0.0001942416,0.01168713,0.002593522,0.0004383527,0.00712292,0.004894594,0.0009145069,0.005672335,0.0001798848],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937584,0.004827874,0.0002267443,0.0001810423,0.00002385077,0.00006120464,0.0004528038,0.00002265581,0.000445414],"genre_scores_gemma":[0.9980324,0.000916832,0.0001652317,0.0001838439,0.00004399577,0.00003608619,0.0004692794,0.00000744029,0.0001448579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002185695,"threshold_uncertainty_score":0.01155913,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03294610948529814,"score_gpt":0.3865217980239725,"score_spread":0.3535756885386743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}